Emicizumab
| Product Overview | |
| Generic Name | Emicizumab |
| Brand Name(s) | Hemlibra |
| Form | Solution for injection, sub-C, single-dose vial |
| Strength | 30mg/mL |
| Therapeutic Class | Routine prophylaxis to prevent/reduce bleeding in hemophilia A |
| ATC Code | B02BX06 |
| Manufacturing & Regulatory | |
| Manufacturer | Genentech |
| Country | USA |
| COFEPRIS | 010.000.6199.00 |
| Free Sale Certificate | Potentially available depending on exporting jurisdiction |
| Logistics & Export | |
| MOQ | 10 |
| Shelf Life | 24 Months |
| Storage | Refrigerated (2–8 °C) |
| Incoterms | Ex-Works Mexico |
| Lead Time | 7 - 10 Business Days |
| Documentation | |
| Certificate of Analysis (COA) | Typically available as batch/lot CoA |
Description
subcutaneous prophylaxis to prevent or reduce bleeding in hemophilia A patients
